Author:
Wyant Tim,Leach Tim,Sankoh Serap,Wang Yuemei,Paolino Jonathan,Pasetti Marcela F,Feagan Brian G,Parikh Asit
Reference27 articles.
1. The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases;Soler;J Pharmacol Exp Ther,2009
2. Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes;Erle;J Immunol,1994
3. Regional and mucosal memory T cells;Sheridan;Nat Immunol,2011
4. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety;Dubinsky;Clin Gastroenterol Hepatol,2004
5. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREATTM registry;Lichtenstein;Am J Gastroenterol,2012
Cited by
150 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献